Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute

Florencia Carbone,Christian Peetermans,Céline Tack,Olivier Gernay,Hubert Piessevaux,Alain Vandenberghe,Linde Besard,Luc Capiau,Jessica R Biesiekierski ,Lydia Jones,Lukas Van Oudenhove,Olivia Vandeput,Philip Caenepeel,W.k De Raat ,Sophie Van Steenbergen,Joris Arts,Rudy Van Boxstael,Jeroen Stubbe,Michael P Jones ,Tim Vanuytsel,Karen Van Den Houte,Sophie Maes,Christophe Matthys,Steven Ceulemans,Jan Tack

doi:10.1136/gutjnl-2021-325821

Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute

Florencia Carbone, Christian Peetermans + Show 23 more

Open Access

https://doi.org/10.1136/gutjnl-2021-325821

Copy DOI

Journal: Gut	Publication Date: Apr 28, 2022
Citations: 28	License type: open-access

Affiliation: KU Leuven, Université Catholique de Louvain, La Trobe University, Ziekenhuis Oost-Limburg, Macquarie University

#Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols #Belgian Health Care Knowledge Centre + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

BackgroundIn Europe, IBS is commonly treated with musculotropic spasmolytics (eg, otilonium bromide, OB). In tertiary care, a low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet provides significant improvement. Yet,...

Full Text